MOUNTAINSIDE, N.J., Oct. 6, 2016 /PRNewswire/ -- Androvia LifeSciences, a biotechnology company engineering solutionsfor the advancement of male fertility, today announced that data related to the company's proprietary technology, the Cap-Score™ Sperm Function Test, will be presented in three poster sessions at the 72nd Annual American Society
"Because this new assay is able to help clinicians determine the specific fertility treatment that is most suitable for each couple, it is inherently able to reduce overall costs while increasing the pregnancy rate," said Joseph B. Babigumira, PhD, Departments of Pharmacy and Global Health, University of Washington, who led the study being presented at ASRM exploring the reduction in medical costs associated with use of the Cap-Score Sperm Function Test.
The studies related to Cap-Score that are being presented at the ASRM annual conference this year consist of:
Capacitation defects are common in men questioning their fertility and are independent of standard semen analysis parameters
Potential Impact of the Cap-Score test on clinical pregnancy and medical costs in couples with unexplained infertility
Capacitation timing varies among men, but is consistent among ejaculates within individuals
Abstracts summarizing these data are available on the ASRM website at: http://scientific.asrmcongress.org/Portals/1/2016PDFs/2016AbstractSupplement.pdf?ver=2016-09-09-093055-120
About Cap-Score Sperm Function Test
A laboratory developed test designed to assess and measure the fertilizing ability of sperm, to help couples and reproductive health care professionals make informed decisions about the fertility solution that is best suited for that couple. The Cap-Score Sperm Function Test provides an analysis of the sperm on a molecular level, and is the only assay that evaluates capacitation, the process by which sperm acquire the ability to fertilize an egg. The test is being designed to complement the traditional semen analysis which determines sperm count, motility and appearance.
About Androvia LifeSciences
Androvia LifeSciences is a biotechnology company focused on engineering scientific technology for the advancement of male fertility, and empowering men with the information to help determine personalized fertility solutions. It is among only a few companies in the world focused on male fertility today.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/three-studies-conveying-benefits-of-new-male-fertility-assay-to-be-presented-at-scientific-congress-of-the-american-society-for-reproductive-medicine-asrm-300340684.html
SOURCE Androvia LifeSciences
Subscribe to our Free Newsletters!
Proper understanding of waste collection, segregation and management is required to reduce the ...
Leukoplakia refers to a painless, raised white patch in the mouth that does not go away on rubbing, ...
Health insurance has emerged one of the fastest growing segments in the non-life insurance industry ...View All